Supplementation with oleoylethanolamide (OEA) could significantly increase the body’s production of GLP-1, according to new findings published in Frontiers in Endocrinology.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.